Phagenesis Raises $42M to Treat Swallowing Dysfunction Globally
Phagenesis, a Manchester, UK-based company which has developed a neurostimulation system to treat swallowing dysfunction, recently announced the closing of a $42M Series D financing round. The funding was led by EQT Life Sciences and Sectoral Asset Management, with participation from new investors British Patient Capital, Northern Gritstone, and Aphelion. The company plans to utilize the funds to expand its operations and development efforts across various regions.
Co-founded by Dr.
Conor Mulrooney and Professor Shaheen Hamdy from the University of Manchester in 2007, Phagenesis is at the forefront of providing innovative treatments for neurogenic dysphagia using pharyngeal electrical stimulation, PES. The Phagenyx® Neurostimulation System focuses on restoring the neurological components of swallowing coordination and control that are disrupted due to brain injury or prolonged mechanical ventilation. This groundbreaking technology has the potential to improve the quality of life for patients suffering from swallowing dysfunction.
With the recent approval of Phagenyx® by the FDA in the United States, the company is now focused on commercialization in the US and expanding its reach in Europe. Reinhard Krickl, CEO of Phagenesis, highlighted the importance of investing in exceptional talent to scale up customer outreach and support clinicians passionate about bringing their therapy to those in need. By addressing the critical issue of dysphagia, Phagenesis aims to make a positive impact on the lives of millions of patients worldwide.
They've invested in Phagenesis
Get to know these Biotech investors
| # | Investor | Sector | Stage | Activity | Team | Connect |
|---|---|---|---|---|---|---|
1 |  EQT Life Sciences | 1 investment(s) investment(s) | more info | |||
2 |  Sectoral Asset Management | 1 investment(s) investment(s) | more info | |||
3 |  British Patient Capital | 10 investment(s) investment(s) | 25 contacts contacts | |||
4 |  Northern Gritstone | 9 investment(s) investment(s) | more info | |||
5 |  Aphelion | 1 investment(s) investment(s) | 3 contacts contacts |
Click here for a full list of 6,528+ startup investors in the UK